Catalyst Wire Dossier Catalyst Wire Dossier

AnchorMan Left Atrial Appendage Occluder

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AnchorMan Left Atrial Appendage Occluder, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke [NA]

See pricing